Keywords: نوع مهار کننده فعال کننده پلاسمینوژن 1; single miscarriage; recurrent miscarriage; genetic alterations; chromosome abnormalities; genetic polymorphisms; karyotype; ACE; Angiotensin I converting enzyme; Bcl-2; B-cell lymphoma 2; CGH; comparative genomic hybridization; CYP; cytochrome P450; CTLA-
مقالات ISI نوع مهار کننده فعال کننده پلاسمینوژن 1 (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: نوع مهار کننده فعال کننده پلاسمینوژن 1; aPTT; activated partial thromboplastin time; AT; antithrombin; CAT; calibrated automated thrombography; ETP; endogenous thrombin potential; F1Â +Â 2; prothrombin fragments F1Â +Â 2; FII; prothrombin; FVIII:C; factor VIII coagulant activity; IDDM; insulin-
Keywords: نوع مهار کننده فعال کننده پلاسمینوژن 1; Asthma; severity; airway inflammation; hemostasis; coagulation; fibrinolysis; comorbidity; CRP; C-reactive protein; ETP; Endogenous thrombin potential; PAI-1; Plasminogen activator inhibitor type 1; PAPc; Plasmin-α2-antiplasmin complex; PE; Pulmonary emb
Keywords: نوع مهار کننده فعال کننده پلاسمینوژن 1; CPI; carboxypeptidase inhibitor; ECLT; euglobulin clot lysis time; FXIIIa; activated factor XIII; IAA; iodoacetamide; PAI-1; plasminogen activator inhibitor type 1; s-PCLT; spontaneous plasma clot lysis time; TAFI; thrombin activatable fibrinolysis inhibi
Keywords: نوع مهار کننده فعال کننده پلاسمینوژن 1; AUC30; area under the flow pressure curve; CFT; clot formation time; CT; clotting time; CTI; corn trypsin inhibitor; MCF; maximum clot firmness; ML; maximum lysis; OT; occlusion time; PAI-1; plasminogen activator inhibitor type 1; ROTEM; rotational thromb
Keywords: نوع مهار کننده فعال کننده پلاسمینوژن 1; Type 1 diabetes; Diabetes complications; Retinopathy; Biomarkers; E-selectin; Plasminogen activator inhibitor type 1;
Keywords: نوع مهار کننده فعال کننده پلاسمینوژن 1; cross-linked fibrin degradation products by leukocyte elastase (e-XDP); d-dimer; soluble fibrin monomer complex; plasminogen activator inhibitor type 1; total knee arthroplasty; venous thromboembolism
Keywords: نوع مهار کننده فعال کننده پلاسمینوژن 1; CVD; cardiovascular disease; USDA; United States Department of Agriculture; MUFA; monounsaturated fatty acids; GI; glycaemic index; MUFObes; Mono Unsaturated Fatty acids in Obesity; LF; low-fat; BMI; body mass index; FVII; factor VII; TAFI; thrombin activ
Keywords: نوع مهار کننده فعال کننده پلاسمینوژن 1; ATM; ataxia telangiectasia mutated; ATP; adenosine triphosphate; Chk2; checkpoint kinase 2; DNA-PKcs; DNA-dependent protein kinase catalytic subunit; DUSP; dual-specificity phosphatase; HIV; human immunodeficiency virus; IL; interleukin; MCP1; monocyte ch
Keywords: نوع مهار کننده فعال کننده پلاسمینوژن 1; ABC; ATP binding cassette transporter; AMPK; AMP kinase; AP; activator protein; Akt; protein kinase B; Apo; apolipoprotein; apoB48R; apolipoprotein B48 receptor; CD; cluster of differentiation; CM; chylomicrons; CMR; chylomicron remnants; COX; cyclooxygen
Adipocytes spectrum - From homeostasia to obesity and its associated pathology
Keywords: نوع مهار کننده فعال کننده پلاسمینوژن 1; Acrp30 (AdipoQ); adiponectin gene; AdipoR; adiponectin receptor; AGE; angiotensinogen; ALP; alkaline phosphatase; Ang II; angiotensin II; Angptl2; angiopoietin-like protein-2; Aqp7; aquaporin-7; aP2; adipocyte-specific fatty acid binding protein 2 gene; A
Mechanisms of Vascular Dysfunction in COPD and Effects of a Novel Soluble Epoxide Hydrolase Inhibitor in Smokers
Keywords: نوع مهار کننده فعال کننده پلاسمینوژن 1; clinical trial; COPD; EETs; endothelial function; smokers; soluble epoxide hydrolase inhibitor; CYP; cytochrome P450; DHET; dihydroxyepoxyeicosatrienoic acid; EC50; half maximal effective concentration; EDHF; endothelium-derived hyperpolarizing factor; EE
Chemical composition and “in vitro” anti-inflammatory activity of Vitis vinifera L. (var. Sangiovese) tendrils extract
Keywords: نوع مهار کننده فعال کننده پلاسمینوژن 1; CAD; coronary artery disease; CVD; cardiovascular disease; DPPH; diphenylpicrylhydrazyl; HPLC-DAD; high-performance liquid chromatography with diode-array detection; IRAK-1; IL-1 receptor-associated kinase 1; LPS; lipopolysaccharide; MIRAKIL; biomarkers a
Carbamylated Low-Density Lipoproteins Induce a Prothrombotic State Via LOX-1
Keywords: نوع مهار کننده فعال کننده پلاسمینوژن 1; aggregation; arterial thrombosis; chronic kidney disease; platelets; vascular smooth muscle cells; AoSMC; aortic smooth muscle cell; CKD; chronic kidney disease; cLDL; carbamylated low-density lipoprotein; HAEC; human aortic endothelial cell; LDL; low-de
HIF-2alpha-dependent PAI-1 induction contributes to angiogenesis in hepatocellular carcinoma
Keywords: نوع مهار کننده فعال کننده پلاسمینوژن 1; HCC; hepatocellular carcinoma; HIF; hypoxia-inducible factor; k/d; knockdown; PAI-1; plasminogen activator inhibitor type 1; VEGF; vascular endothelial growth factor; cv; control virus; Plasmin; Aprotinin; Tumor hypoxia; Spheroid-embryonic body-coculture;
Antithrombotic and profibrinolytic activities of phloroglucinol
Keywords: نوع مهار کننده فعال کننده پلاسمینوژن 1; aPTT; activated partial thromboplastin time; AT III; antithrombin III; ERK; extracellular signal-regulated kinase; FX; factor X; JNK; c-Jun N-terminal kinase; NF-κB; nuclear factor factor-κB; PAI-1; plasminogen activator inhibitor type 1; PT; prothrombi
Effects of chronic cigarette smoking on endothelial function in young men
Keywords: نوع مهار کننده فعال کننده پلاسمینوژن 1; Smoking; Flow-mediated vasodilation; Plasminogen activator inhibitor type 1; Nitric oxide; Endothelium
Plasminogen activator inhibitor-1 regulates neutrophil influx during acute pyelonephritis
Keywords: نوع مهار کننده فعال کننده پلاسمینوژن 1; fibrinolytic system; immunology and pathology; pyelonephritis; plasminogen activator inhibitor type 1
Unequal tissue expression of proteins from the PA/PAI system, myoma necrosis, and uterus survival after uterine artery occlusion
Keywords: نوع مهار کننده فعال کننده پلاسمینوژن 1; Myoma; Plasminogen activator inhibitor type 1; Tissue plasminogen activator; Urokinase plasminogen activator; Uterine artery occlusion;
C-reactive protein is directly related to plasminogen activator inhibitor type 1 (PAI-1) levels in diabetic subjects with the 4G allele at position −675 of the PAI-1 gene
Keywords: نوع مهار کننده فعال کننده پلاسمینوژن 1; C-reactive protein; Fibrinolysis; PAI-1 genotype; Plasminogen activator inhibitor type 1; Type 2 diabetes
A study on the action of vitamin E supplementation on plasminogen activator inhibitor type 1 and platelet nitric oxide production in type 2 diabetic patients
Keywords: نوع مهار کننده فعال کننده پلاسمینوژن 1; Type 2 diabetes mellitus; Vitamin E; Plasminogen activator inhibitor type 1; Nitric oxide; Na+/K+-ATPase
Urothelial Inhibition of Transforming Growth Factor-β in a Bladder Tissue Recombination Model
Keywords: نوع مهار کننده فعال کننده پلاسمینوژن 1; urothelium; bladder; transforming growth factors; transfection; mesoderm; ABC; avidin-biotin complex; DAB; 3,3â²-diaminobenzidine tetrahydrochloride; DNIIR; dominant negative form of type II TGF-β receptor; EGFP; enhanced green fluorescence peptide; FAC
The PAI-1 4G/5G Gene Polymorphism and Ischemic Stroke: An Association Study and Meta-Analysis
Keywords: نوع مهار کننده فعال کننده پلاسمینوژن 1; Stroke; cerebrovascular accident; genetic polymorphisms; tissue-type plasminogen activator; plasminogen activator inhibitor type 1; genetic association study
Differences in circadian variations of tissue factor pathway inhibitor type 1 between able-bodied and spinal cord injured
Keywords: نوع مهار کننده فعال کننده پلاسمینوژن 1; TFPI; Tissue factor pathway inhibitor; FXa; Activated factor X; LDL; Low density lipoprotein; HDL; High density lipoprotein; VLDL; Very low density lipoprotein; TG; Triglycerides; OC; Oral contraceptives; HRT; Hormone replacement therapy; PAI-1; Plasminog
Proinflammatory Cytokines, Transforming Growth Factor-β1, and Fibrinolytic Enzymes in Loculated and Free-Flowing Pleural Exudates
Keywords: نوع مهار کننده فعال کننده پلاسمینوژن 1; fibrinolysis; loculation; malignancy; pleural effusion; proinflammatory cytokines; tuberculosis; IL; interleukin; IQR; interquartile range; LDH; lactate dehydrogenase; PA; plasminogen activator; PAI-1; plasminogen activator inhibitor type 1; RPT; residual
Levels of the adipocyte-derived plasma protein, adiponectin, have a close relationship with atheroma
Keywords: نوع مهار کننده فعال کننده پلاسمینوژن 1; ABPI; ankle/brachial pressure index; apo; apolipoprotein; baPWV; brachial and ankle pulse wave velocity; BMI; body mass index; CAD; coronary artery disease; CRP; C-reactive protein; ELISA; enzyme-linked immunosorbent assay; HDL-C; high-density lipoprotein
Tissue plasminogen activator in the bed nucleus of stria terminalis regulates acoustic startle
Keywords: نوع مهار کننده فعال کننده پلاسمینوژن 1; stress; c-fos; ACSF; artificial cerebrospinal fluid; BNST; bed nucleus of stria terminalis; CRF; corticotropin-releasing factor; NMDA; N-methyld-aspartate; PAI-1; plasminogen activator inhibitor type 1; PBS; phosphate-buffered saline; PVN; paraventricular
Adenoid Cystic Carcinoma
Keywords: نوع مهار کننده فعال کننده پلاسمینوژن 1; adenoid cystic carcinoma; recurrence; invasion and metastasis; urokinase-type plasminogen activator (uPA); uPA receptor; plasminogen activator inhibitor type 1; matrix degradation; integrins; cell migration; focal adhesion;
Genomic and functional characterization of stellate cells isolated from human cirrhotic livers
Keywords: نوع مهار کننده فعال کننده پلاسمینوژن 1; Liver fibrosis; Cell activation; Collagen; Microarray; Portal hypertension; Ang II; angiotensin II; AT1; angiotensin receptor type 1; BKCa; big potassium-dependent calcium channel; ECM; extracellular matrix; FBS; fetal bovine serum; HSCs; hepatic stellate
Dietary fatty acids and the haemostatic system
Keywords: نوع مهار کننده فعال کننده پلاسمینوژن 1; Dietary fatty acids; Clotting factors; Factor VII; Fibrinolysis; Plasminogen activator inhibitor type 1; Coronary disease;